Matt Smith

Prior to joining VS Health Group, Matt’s most recent experience was Vice President of Global Market Access at Kronos Bio, proceeded by a role as Vice President and Head, Market Access, Distribution and Supply Chain at Oncopeptides, Inc. where he helped build the US-based team and launch of a first-in-class hematology drug. Preceding that role, Matt was Executive Director, Market Access at Dynavax Technologies, responsible for trade, pricing, contract operations, heath economics, managed care marketing, payer engagement, and patient hub operations. Prior to those roles, Matt worked as a Director of Market Access at XOMA, proceeded by a role as Associate Director, Market Access Strategy at Medivation.  He spent 8 years in Genentech in roles of increasing responsibility in market analysis and strategy and managed care marketing for marketed and development-stage oncology products.